Gene: ZNF410
Official Full Name: zinc finger protein 410provided by HGNC
Gene Summary: Enables DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in negative regulation of gene expression and positive regulation of transcription by RNA polymerase II. Predicted to be located in chromosome. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12255 | ZNF410 Knockout cell line (HeLa) | Human | ZNF410 | 1:3~1:6 | Negative | Online Inquiry |
KO12256 | ZNF410 Knockout cell line (HCT 116) | Human | ZNF410 | 1:2~1:4 | Negative | Online Inquiry |
KO12257 | ZNF410 Knockout cell line (HEK293) | Human | ZNF410 | 1:3~1:6 | Negative | Online Inquiry |
KO12258 | ZNF410 Knockout cell line (A549) | Human | ZNF410 | 1:3~1:4 | Negative | Online Inquiry |
ZNF410 Gene Knockout Cell Lines are genetically engineered cellular models designed to facilitate in-depth research of the ZNF410 gene's role in various biological processes. These cell lines are generated using advanced CRISPR-Cas9 technology to efficiently disrupt the expression of the ZNF410 gene, allowing researchers to elucidate its function in cellular differentiation, gene regulation, and developmental pathways.
The key mechanism underlying these knockout cell lines involves the targeted introduction of double-strand breaks in the ZNF410 gene, leading to frameshift mutations and resulting in the complete cessation of ZNF410 protein production. This enables scientists to investigate the consequent phenotypic changes and signaling pathways affected by the absence of ZNF410, thus providing valuable insights into its implications in disease states such as cancer and neurodevelopmental disorders.
The scientific importance of ZNF410 Gene Knockout Cell Lines extends to their applications in both basic research and translational medicine. They serve as a critical resource for dissecting the gene's biological functions and can be leveraged in drug discovery, gene therapy development, and molecular pathway investigations, making them invaluable tools for understanding complex genetic interactions.
One of the distinct advantages of ZNF410 Gene Knockout Cell Lines over other gene editing technologies is their reliability and reproducibility. The CRISPR-Cas9 approach ensures precise targeting and minimizes off-target effects, providing researchers with confidence in their experimental outcomes. Furthermore, these cell lines are readily available and can be easily integrated into existing workflows, enhancing their usability across various research labs.
For researchers and clinicians, ZNF410 Gene Knockout Cell Lines represent a significant investment into their research capabilities, offering a robust platform to advance the understanding of gene function and its relation to human health. By utilizing these cell lines, they can uncover new therapeutic targets and develop innovative strategies for treatment.
Our company specializes in providing high-quality, ready-to-use biological products that meet the rigorous standards of academic and clinical research. With a commitment to advancing scientific knowledge, we ensure that our offerings, including ZNF410 Gene Knockout Cell Lines, are designed to facilitate breakthroughs in understanding complex biological phenomena.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.